Breaking: Trump administration is moving forward with plans to reclassify marijuana as a Schedule III substance. For context, that's the same category as ketamine and anabolic steroids—drugs considered to have lower abuse potential compared to Schedule I or II.

This shift could reshape the entire cannabis industry landscape. We're talking potential federal tax relief for operators, easier banking access, and possibly a catalyst for related assets. Some cannabis tokens already reacting to the news.

Whether you're bullish on the sector or not, policy changes like this tend to create short-term volatility and long-term structural shifts. Worth keeping on your radar.